Literature DB >> 36199003

Flicker electroretinogram in newborn infants.

James V M Hanson1, Caroline Weber2, Oliver A Pfäffli3, Dirk Bassler2, Daphne L McCulloch4, Christina Gerth-Kahlert5.   

Abstract

PURPOSE: To develop and validate a flicker electroretinogram (ERG) protocol in term-born neonates as a potential tool for assessing preterm infants at risk of developing retinopathy of prematurity.
METHODS: A custom flicker ERG protocol was developed for use with the hand-held RETeval® electrophysiology device. Feasibility of measuring flicker ERG through closed eyelids and without mydriasis was established in a pilot study enabling optimisation of the test protocol. Following this, healthy term-born neonates (gestational age 37-42 weeks) were recruited at the Neonatology clinic of the University Hospital Zurich. Flicker ERG recordings were performed using proprietary disposable skin electrodes during the first four days of life when the infants were sleeping. Flicker stimuli were presented at 28.3 Hz for a stimulus series at 3, 6, 12, 30, and 50 cd·s/m2, with two measurements at each stimulus level. Results were analysed offline. Flicker ERG peak times and amplitudes were derived from the averaged measurements per stimulus level for each subject.
RESULTS: 28 term-born neonates were included in the analysis. All infants tolerated the testing procedure well. Flicker ERG recording was achieved in all subjects with reproducible flicker ERG waveforms for 30 and 50 cd·s/m2 stimuli. Reproducible ERGs were recorded in the majority of infants for the weaker stimuli (with detectable ERGs in 20/28, 25/28, and 27/28 at 3, 6, and 12 cd·s/m2, respectively). Flicker ERG amplitudes increased with increasing stimulus strength, with peak times concurrently decreasing slightly.
CONCLUSION: Flicker ERG recording is feasible and reliably recorded in sleeping neonates through closed eyelids using skin electrodes and without mydriasis. Flicker ERG amplitude decreases for lower luminance flicker but remains detectable for 3 cd·s/m2 flicker in the majority of healthy term-born neonates. These data provide a basis to study retinal function in premature infants using this protocol.
© 2022. The Author(s).

Entities:  

Keywords:  Electroretinogram; Flicker ERG; Human neonate; Newborn infant; Retinal development

Year:  2022        PMID: 36199003     DOI: 10.1007/s10633-022-09889-5

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   1.854


  17 in total

1.  The development of parafoveal and mid-peripheral human retina.

Authors:  A Hendrickson; D Drucker
Journal:  Behav Brain Res       Date:  1992-07-31       Impact factor: 3.332

2.  Development of the electroretinogram between 30 and 50 weeks after conception.

Authors:  Ruth Hamilton; John Dudgeon; Michael S Bradnam; Helen Mactier
Journal:  Early Hum Dev       Date:  2004-12-08       Impact factor: 2.079

3.  Development of scotopic visual thresholds in retinopathy of prematurity.

Authors:  Amber M Barnaby; Ronald M Hansen; Anne Moskowitz; Anne B Fulton
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

4.  Maturation of rod function in preterm infants with and without retinopathy of prematurity.

Authors:  Ruth Hamilton; Michael S Bradnam; John Dudgeon; Helen Mactier
Journal:  J Pediatr       Date:  2008-07-14       Impact factor: 4.406

5.  The rhodopsin content of human eyes.

Authors:  A B Fulton; J Dodge; R M Hansen; T P Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-07       Impact factor: 4.799

Review 6.  Screening Examination of Premature Infants for Retinopathy of Prematurity.

Authors:  Walter M Fierson
Journal:  Pediatrics       Date:  2018-12       Impact factor: 7.124

Review 7.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

8.  Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids.

Authors:  D G Birch; E E Birch; D R Hoffman; R D Uauy
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-07       Impact factor: 4.799

9.  International variations and trends in the treatment for retinopathy of prematurity.

Authors:  Brian A Darlow; Kei Lui; Satoshi Kusuda; Brian Reichman; Stellan Håkansson; Dirk Bassler; Neena Modi; Shoo K Lee; Liisa Lehtonen; Maximo Vento; Tetsuya Isayama; Gunnar Sjörs; Kjell K Helenius; Mark Adams; Franca Rusconi; Naho Morisaki; Prakesh S Shah
Journal:  Br J Ophthalmol       Date:  2017-03-07       Impact factor: 4.638

Review 10.  Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010.

Authors:  Hannah Blencowe; Joy E Lawn; Thomas Vazquez; Alistair Fielder; Clare Gilbert
Journal:  Pediatr Res       Date:  2013-12       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.